Table 1

Patient demographics
Patient no.
 Age (years)
 Tumor size (mm)
 Node status
 ER status
 PgR status
 Clinical response
 Pathological finding (after chemotherapy)
1
 42
 7
 +
 +
 n/a
 CR
 No surgery
2
 37
 50
 +
 +
 n/a
 MRD
 No surgery
3
 50
 19
 +
 +
 n/a
 MRD
 DCIS only
4
 56
 24
 -
 -
 n/a
 MRD
 No surgery
5
 56
 50
 +
 -
 n/a
 MRD
 DCIS only
6
 48
 50
 +
 -
 n/a
 SD
 RID
7
 64
 40
 +
 -
 -
 PR
 RID
8
 47
 30
 -
 +
 n/a
 SD
 RID
9
 51
 50
 -
 +
 n/a
 PR
 RID
10
 67
 30
 -
 -
 -
 SD
 RID

CR, complete clinical response (no residual palpable disease); ER, estrogen receptor; MRD, minimal residual disease (residual palpable irregularity that was too small to be measured); n/a, not available; PgR, progestrogen receptor; PR, partial response (more than 50% reduction in bidimensional measurement); SD, stable disease (between 50% reduction and 25% increase in bidimensional measurement); RID, residual invasive disease; DCIS, ductal carcinoma in situ.

Sotiriou et al. Breast Cancer Res 2002 4:R3   doi:10.1186/bcr433